The morning sickness drug was driven from the market in 1983 by a wave of lawsuits even though health authorities and most juries agreed then and now that it does not cause birth defects; it has been available in Canada all along under the name Diclectin. Bright Line notices that the March of Dimes, which specializes in birth defects prevention, wants the drug back. See Overlawyered, Jul. 21, 1999 and Sept. 27-28, 2000.
March of Dimes wants Bendectin back
![]() |
Rafael Mangual Project Manager, Legal Policy rmangual@manhattan-institute.org |
![]() |
Communications Manhattan Institute communications@manhattan-institute.org |